Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Glucokinase regulatory protein (GKRP), encoded by the GCKR gene, is a key regulator of glucokinase (GK) activity and intracellular localization in hepatocytes. It controls hepatic glucose uptake, glycogen synthesis, glycolysis, and blood glucose homeostasis. GKRP binds to GK, sequestering it in the nucleus when glucose levels are low and releasing it into the cytoplasm when glucose levels rise. Variants in GCKR are associated with metabolic disorders such as type 2 diabetes and NAFLD, making it a potential drug target. Therapeutic strategies aim to modulate GK-GKRP interaction to restore balanced hepatic carbohydrate/lipid metabolism, avoiding the side effects associated with direct glucokinase activation.
Modulation of GK-GKRP binding, allosteric activation/inhibition of interaction, mimicking physiological regulators like F1P/F6P.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glucokinase Regulatory Protein (GKRP).